Investor Presentaiton

HORIZONTALLY DIVERSIFIED VERTICALLY INTEGRATED High Margin Strategy A Sustainable Long-term Business Model Maximizing average selling price through. Leadership in key international markets allowing strategic focus on highest margin options (medical, new products) Full margin capture in international markets through direct ownership of distribution channels Commitment to science and product development > developing new higher margin products and marketable IP Driving down overall production per gram cash costs through. Commitment to science and technology > increasing yields through genetics, low per gram operating costs from world-class automation and replicable large-scale pharma-style production Low input-cost locations Leveraging massive scale to spread costs over a large volume of product Production costs at scale are projected to be well below $1 per gram AURORA 21

View entire presentation